Related Experiment Video
Updated: Jan 20, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
[Resection margins in soft tissue sarcomas]
B Rath1, J Hardes2, M Tingart3
1Klinik für Orthopädie, Uniklinik RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland. brath@ukaachen.de.
Background:
Soft tissue sarcomas (STS) are a rare and heterogeneous group of malignant tumors that arise from the mesenchymal tissue. STS can form anywhere in the human body, with the extremities being preferred sites of predilection.
Treatment:
A fundamental pillar of treatment is the surgical resection of soft tissue sarcomas. The goal is always an R0 resection with a safety margin. There is no consensus in the literature about the desired tumor-free resection margin. The decisive factors for these resection margins are histopathology, presence of anatomical barriers (capsule, tendon, fascia, cartilage, periosteum) and possibilities of (neo-) adjuvant therapy.
Discussion:
References in the literature support the role of resection margins as a predictor of local recurrence. Regarding the role of resection margins in overall survival, available data is divergent. There are known prognostic factors that influence overall survival, such as histological subtype, tumor size, tumor grading, and presence of metastases. So far, several studies have attempted to quantify the margins of resection, but no consensus has been reached, and debates are ongoing. When analyzing all the results of the data in the literature, it seems appropriate to aim for a negative resection margin >1 mm including an anatomical border structure, if possible.
Related Concept Videos
07:55Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
04:45Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
11:42Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
07:49Isolating Stem Cells from Soft Musculoskeletal Tissues
12:44The In ovo CAM-assay as a Xenograft Model for Sarcoma

